Bloomfield Hills, MI (PRWEB) January 24, 2013
Less than 5 percent of Americans know where to find information about clinical trials, according to the Center for Information & Study on Clinical Research. cureLauncher solves that problem. It gives everyone a place to find new treatments and connect with lifesaving treatment options.
Now, cureLauncher has every enrolling breast cancer trial in the country available on its website. There are 400 trials at 7,500 locations across the U.S. that offer new breast cancer treatment options. cureLauncher has translated the complex, medical terminology into easy to understand English.
When people visit cureLauncher, they can review information about these trials and the entry questions to see if a trial is right for them. Anyone can complete the Request Form to participate or call cureLauncher directly to see if they qualify. This service is free to all users.
cureLauncher’s founders, Stephen Goldner and David Fuehrer, appeared on the Stupid Cancer Radio Program live from New York City on January 21st to discuss trial options. “cureLauncher makes it easy for people to find treatment that’s right for them”, said David Fuehrer. “Our mission is to provide a place where people feel comfortable learning about clinical trials and cutting edge, new medical treatments”.
Dr. Max Wicha, Director of the University of Michigan’s Cancer Center, was on the Stupid Cancer Show with cureLauncher. “Only about 3 percent of cancer patients decide to enter a clinical trial, even though the very best treatment for them may be in a trial”, said Dr. Wicha. “Particularly now, when we have so many new options to treat cancer it’s so important that patients understand they have options to get advantages of these leading treatments”.
To learn more, visit http://www.curelauncher.com
CureLauncher.com is an online community that connects people to lifesaving clinical trials across the U.S. Discover your power to find new cancer treatment options, right now.
Read the full story at http://www.prweb.com/releases/New_Cancer_Treatments/cureLauncher/prweb10356876.htm.
Copyright©2012 Vocus, Inc.
All rights reserved